<DOC>
	<DOCNO>NCT00005520</DOCNO>
	<brief_summary>To determine whether measured variation gene cod component vasoconstriction volume regulate system predict interindividual difference blood pressure response therapy thiazide diuretic , hydrochlorothiazide , angiotensin II receptor blocker , candesartan , hypertensive African-Americans ( N=300 treat drug ) hypertensive European Americans ( N=300 treat drug ) .</brief_summary>
	<brief_title>Genetic Epidemiology Responses Antihypertensives</brief_title>
	<detailed_description>BACKGROUND : Essential hypertension common disorder contributes morbidity , mortality , cost health care , especially among African-Americans . Although single-drug therapy commonly prescribe treatment hypertension , blood pressure level control individual others . The study potential identify gene contribute etiology interindividual difference blood pressure response diuretic therapy African-Americans European Americans . DESIGN NARRATIVE : Hypertensive adult treat diuretic hydrochlorothiazide , 25 mg/day , four week ; angiotensin II receptor blocker candesartan , 16 mg/day 2 week follow 32 mg/day 4 week . Interindividual variation blood pressure responses candidate gene cod component system regulate vasoconstriction volume measure . In addition , panel 500,000 single nucleotide polymorphism genome-wide measured subset extreme responder nonresponders drug genome-wide association analysis .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Primary ( essential ) hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Hydrochlorothiazide</keyword>
	<keyword>Candesartan</keyword>
</DOC>